Sign In
Buy HALO
$69.82
+3.54 (+5.34%)
At Close: Jun 03, 2026
HALOZYME REPORTS SECOND QUARTER 2024 FINANCIAL AND OPERATING RESULTS
04:01pm, Tuesday, 06'th Aug 2024
Total Revenue of $231 million; Net Income of $93 million; Adjusted EBITDA of $137 million; GAAP Diluted EPS of $0.72 and Non-GAAP Diluted EPS of $0.91 1 Royalty Revenue Increased 12% YOY to $125 milli
4 Stocks That Flaunt an Impressive Interest Coverage Ratio
12:01pm, Tuesday, 06'th Aug 2024
A company that is capable of generating earnings well above its interest expense can withstand financial hardship. HALO, LDOS, ATO & ADUS are sound enough to meet financial obligations.
Curious about Halozyme Therapeutics (HALO) Q2 Performance? Explore Wall Street Estimates for Key Metrics
10:22am, Monday, 05'th Aug 2024
Beyond analysts' top -and-bottom-line estimates for Halozyme Therapeutics (HALO), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed f
3 Biotech Stocks on Track for 50% Returns (or More) by 2028
01:33pm, Sunday, 04'th Aug 2024
The biotech industry, often recognized for its rapid innovation, can set investors up for outsized returns in the stock market. However, not all biotech companies have the capability of doing so.
5 Biotech Stocks to Bet On Bright Industry Prospects
10:45am, Monday, 29'th Jul 2024
New drug approvals and strong pipeline progress are likely to help maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position MRNA, S
Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
10:45am, Friday, 26'th Jul 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
This Top Medical Stock is a #1 (Strong Buy): Why It Should Be on Your Radar
10:02am, Friday, 26'th Jul 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
Why Halozyme Therapeutics (HALO) is a Top Value Stock for the Long-Term
10:40am, Tuesday, 23'rd Jul 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Halozyme to Report Second Quarter 2024 Financial and Operating Results
08:30am, Tuesday, 23'rd Jul 2024
SAN DIEGO , July 23, 2024 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its second quarter 2024 financial and operating results on Tuesday, Au
4 Stocks With Impressive Interest Coverage Ratio to Buy Now
09:05am, Monday, 22'nd Jul 2024
A company capable of generating earnings well above its interest expense can withstand financial hardship. AMZN, HALO, THC and ATO are sound enough to meet financial obligations.
3 Biotech Stocks That Could Be Multibaggers in the Making: July Edition
07:00am, Thursday, 18'th Jul 2024
The biotech sector possesses a significant predicted Compounding Annual Growth Rate (CAGR) of 14% between 2023 to 2032. But the risks certainly match the rewards.
Add These 5 Hot Biotech Stocks In July
09:22am, Wednesday, 17'th Jul 2024
Investing in biotech stocks can be rewarding. Not just because these stocks have the potential to produce meaningful gains in your portfolio, but also because when you invest in them, you're investing
Big Money Eyes Halozyme for Strong Growth
05:11pm, Tuesday, 16'th Jul 2024
A recent patent approval for biopharmaceutical company Halozyme Therapeutics, Inc. (HALO) resulted in raised 2024 guidance.
3 Biotech Stocks to Buy Now: Q3 Edition
09:04pm, Monday, 15'th Jul 2024
Biotech stocks to buy can be an interesting sector for investors. They can provide massive gains following positive news regarding clinical trials or FDA approvals.
Top Medical Stocks to Buy for Growth & Performance
06:01pm, Wednesday, 10'th Jul 2024
The medical sector is crawling with opportunity as indicated in its representation on the Zacks Rank #1 (Strong Buy) list.
